TY  - JOUR
PY  - 2022//
TI  - Suicidality and COVID-19: suicidal ideation, suicidal behaviors and completed suicides amidst the COVID-19 pandemic (Review)
JO  - Experimental and therapeutic medicine
A1  - Efstathiou, Vasiliki
A1  - Stefanou, Maria-Ioanna
A1  - Siafakas, Nikolaos
A1  - Makris, Michael
A1  - Tsivgoulis, Georgios
A1  - Zoumpourlis, Vassilios
A1  - Spandidos, Demetrios A.
A1  - Smyrnis, Nikolaos
A1  - Rizos, Emmanouil N.
SP  - e107
EP  - e107
VL  - 23
IS  - 1
N2  - Since the outbreak of the coronavirus 2019 (COVID-19) pandemic, there has been widespread concern that social isolation, financial stress, depression, limited or variable access to health care services and other pandemic-related stressors may contribute to an increase in suicidal behaviors. In patients who have recovered from COVID-19, an increased risk of developing suicidal behaviors may be noted, while post-COVID syndrome comprises another potential risk factor contributing to increased suicidal behaviors. Despite the initial alarming predictions for an increase in suicide rates due to the COVID-19 pandemic, the majority of published studies to date suggest that experienced difficulties and distress do not inevitably translate into an increased number of suicide-related deaths, at least not in the short-term. Nevertheless, the long-term mental health effects of the COVID-19 pandemic have yet to be unfolded and are likely to remain for a long period of time. Suicide prevention and measures aiming at promoting well-being and mitigating the effects of COVID-19 on mental health, particularly among vulnerable groups, should thus be a priority for healthcare professionals and policymakers amidst the evolving COVID-19 pandemic.<p />  <p>Language: en</p>
LA  - en
SN  - 1792-0981
UR  - http://dx.doi.org/10.3892/etm.2021.11030
ID  - ref1
ER  -